Read + Share
Amedeo Smart
Independent Medical Education
Herzog BH, Waqar SN, Devarakonda S, Ward JP, et al. Ramucirumab plus atezolizumab in patients with stage IV non-small cell lung cancer previously treated with immune checkpoint inhibitors. Lung Cancer 2022;173:101-106.PMID: 36179540
Email
LinkedIn
Facebook
Twitter
Privacy Policy